Clearmind Medicine to issue $2 million in convertible debt under existing agreement
CMND•Clearmind Medicine plans to issue $2 million in convertible notes under its existing $10 million program, generating $1.8 million in cash proceeds. The closing is expected on or before October 19, 2026.
1. Convertible note issuance
Clearmind Medicine notified investors on October 16, 2026, that it plans to issue $2 million in convertible promissory notes under its existing $10 million program. The notes will generate $1.8 million in cash proceeds at 90% of principal value, with closing expected on or before October 19, 2026.
